Aseptika Ltd (Activ8rlives)

Aseptika Ltd began developing Activ8rlives in 2010 and is currently developing its fourth generation of integrated systems, which can be used by consumers and their healthcare service providers using a wide range of platforms or devices to better enable effective and easy self-monitoring. Incorporating sensors and monitors ranging from consumer accessories to in vitro diagnostics (IVDs). Our focus is: respiratory and cardiovascular disease, cancer, promoting physical activity and weight management. Aseptika specialises in developing smart inhalers for patients with long-term respiratory conditions, which has been co-funded by the UK's Innovation Agency, Innovate UK. Aseptika third-generation smart inhaler tracker, which will have IoT connectivity built-in. This means that patients, young or old, will no longer have to send their data via a smartphone to their clinical teams, carers or parents—it will just send information over the airwaves directly to the Cloud Servers. Aseptika Limited is certified by BSI to ISO 13485:2016 under certificate number MD691414.

• Employees 7
• Founded 2007
• Annual Revenue $3417000